LRI Investments »

Passage Bio shares owned by LRI Investments

Quarter-by-quarter ownership of Passage Bio (PASG) shares owned by LRI Investments from 13F filings

Historical chart of LRI Investments investment in Passage Bio

Tip: Access up to 7 years of quarterly data

All positions including Passage Bio held by LRI Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Passage Bio by LRI Investments

Quarter filed Position value Share count Share price at filing
2024-09-30 $132 225 0.59
2024-06-30 $179 225 0.80
2024-03-31 $303 225 1.35

More positions owned by LRI Investments

Ares Management Corporation Cl A Com Stk Stock (ARES)
Dimensional U.s. Core Equity 2 Etf Etf (DFAC)
Wisdomtree U.s. Largecap Dividend Fund Etf (DLN)
Assured Guaranty Stock (AGO)
Dimensional International Core Equity Market Etf Etf (DFAI)
Dimensional World Ex U.s. Core Equity 2 Etf Etf (DFAX)
Microsoft Corp Stock (MSFT)
Wisdomtree International Equity Fund Etf (DWM)
Meta Platforms Inc Cl A Stock (META)
Amazon Stock (AMZN)
Apple Stock (AAPL)
Trane Technologies Stock (TT)
Vanguard Real Estate Etf Etf (VNQ)
Wisdomtree International Smallcap Dividend Fund Etf (DLS)
Dimensional International Small Cap Value Etf Etf (DISV)

View all positions for LRI Investments

Top funds holding Passage Bio

OrbiMed Advisors
Lynx1 Capital Management
Vestal Point Capital
Erste Asset Management GmbH
Vanguard Group
Tang Capital Management
Renaissance Technologies
Acadian Asset Management
BlackRock
BlackRock
Bridgeway Capital Management
Geode Capital Management
Citadel Advisors
Fiduciary Trust Company
State Street Corporation

View all funds holding Passage Bio